Invest in MJ Blog

Invest In MJ is a multi-author and community member blog. Read the latest blogs about investment ideas in the marijuana and cannabis industry.

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Team Blogs
    Team Blogs Find your favorite team blogs here.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
Recent blog posts

LAS VEGASMay 27, 2015 /PRNewswire/ -- DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGPD) opened the doors of its Las Vegas marijuana analytical testing laboratory for business today. Equipped with state of the art analytical instrumentation and operated under the direction of Cindy Orser, PhD, DigiPath Lab's flagship facility offers cannabis growers and marijuana-based product-makers fast and reliable results.

"This is a great day for the patients of Nevada who will benefit from medical marijuana," said DigiPath Labs president Todd Denkin. "Our analysis not only helps product producers and dispensaries screen out products with dangerous levels of contaminants, we also quantify the medicinal compounds present in samples, so patients and caregivers can choose products that have been shown to relieve their specific symptoms."

Surprisingly, compulsory cannabis testing is relatively new. The State of Colorado only began requiring product testing a year ago after a series of overdoses on edibles made the news. Washington State did not begin requiring testing for potency, contaminants, moisture and microbiology testing until 2013 when recreational cannabis became legal, even though the medicinal use of marijuana became legal in 1998.


Rate this blog entry:

BOCA RATON, FL--(Marketwired - May 29, 2015) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announces positive progress on its High Grade CBD (Cannabidiol) Rich Hemp Oil in vitro studies on various human primary cells with DV Biologics, a leading biological company. In order to assure the public that ETST provides the best High Grade CBD (Cannabidiol) Rich Hemp Oil, we continue to focus on providing the public with sound scientific research and keeping the public informed on the progression of studies being done on our Hemp CBD products. DV Biologics, which is independently testing our ETST High Grade Hemp CBD Oil in vitro on various human primary cells, has informed us of the progression of studies being done. The goals of these studies are to test if ETST High Grade CBD Rich Hemp Oil serves as a neuroprotectant which may help with neurodegenerative disorders.

"Testing compounds in vitro on human cells is difficult. We recently tested various concentrations of ETST High Grade CBD Hemp Oil on various cells to see which concentrations are toxic to cells and noted that the cells grow similarly in concentrations from 1-10 micromolar. This is exciting news as it shows that this product, ETST High Grade CBD Hemp Oil, may be used in varying concentrations without toxicity to different cell types. We are now ready to test whether ETST High Grade CBD Hemp Oil can stop or deter free radical formation that occurs in vitro with brain cells. In order to do so, we will use varying concentrations of ETST Hemp CBD Oil and induce oxidative stress on brain cells. We will then test the cells to see if the ETST Hemp CBD Oil reduces oxidative stress and free radical formation compared to a control cell type that has no ETST High Grade CBD Hemp Oil. We look forward to reporting the full study in the near future," stated Dr. Rafael Gonzalez, Vice President of Research & Development of DV Biologics.

Rate this blog entry:

SAN DIEGO, CA--(Marketwired - May 27, 2015) - MyDx, Inc., (OTC PINK: MYDX), the developer of MyDx™ (My Diagnostic), the first handheld chemical analyzer for consumers, has signed an exclusive patent sublicense agreement with Next Dimension Technologies, Inc. ("NDT"), a developer of electronic nose chemical sensing technology used by NASA, and funded by the Bill & Melinda Gates Foundation.

Under the agreement, NDT will license intellectual property relating to its chemical sensing technology that enables the MyDx Analyzer to sense, measure and report chemicals of interest to its customers. The company has exclusively licensed the use of the sensor technology to characterize and detect compounds in Cannabis.

"Offering the Cannabis Industry a friend in Science & Technology is an exciting step for MyDx," said Daniel Yazbeck, the company's Chairman & CEO. "We currently are the only company offering a practical Cannabis analysis solution at an affordable consumer price point. With this exclusive agreement, we now also have the intellectual property needed to further protect this competitive advantage."

Rate this blog entry:

DENVER, CO--(Marketwired - May 26, 2015) - Blue Line Protection Group, Inc. (OTCBB: BLPG) (OTCQB: BLPG), a leader in providing regulatory compliance, security consultation and protection services to high-value asset industries, today announced the hiring of financial services professional Robin Swinney to its Blue Line Advisory Services team. Created to respond to the licensing and bookkeeping needs of lawful marijuana businesses across the nation, Blue Line Advisory Services is a wholly-owned subsidiary of Blue Line Protection Group.

"We're pleased to have Robin bring her wealth of experience to Blue Line," said Sean Campbell, Blue Line Protection Group's Chief Executive Officer. "Not only do our clients face never-ending revisions to complicated regulations, but they have the incredible burden and time pressure of counting and re-counting cash and accounting for its movements. Robin's expertise will help ensure our clients are able to respond to all reporting requirements of state and federal licensing and regulatory agencies."

Rate this blog entry:

BEVERLY HILLS, CA--(Marketwired - May 26, 2015) -  mCig, Inc. (OTCQB: MCIG), a leading provider of technology, products, and services for consumers, dispensaries, and growers within the global medical and recreational marijuana industry, announced on Tuesday, May 26, 2015 the plan to open a Southern Colorado Cultivation and Extraction Facility. The Extraction Division will oversee the operation of the facility, cultivating and extracting a world-class product for legal consumers in Colorado, allowing mCig to create another stable revenue stream in the cannabis extraction industry, which some analysts predict will reach $47B in revenue in 2016. The blueprint for this pilot facility will also be easily duplicated in other locations. In addition to the plan, mCig announced the completion of an agreement with Denver-based Master Grower and Cannabis Entrepreneur Derek DeCosmo to serve as a Key Partner and consultant for the upcoming Cultivation Facility. Mr. DeCosmo will also be responsible for providing logistical support for the Extraction portion of the Facility. 

Mr. DeCosmo has over a decade of professional growing experience as well as an extensive network of farmers and dispensaries across the state from which to pool resources. Mr. DeCosmo has worked with Personal Organic Therapies in Denver in the past, and is extremely excited to be involved with the mCig Southern Colorado Operation. Mr. DeCosmo commented, "When Mike Snody (mCig's Chief Research and Development Officer) laid out the master plan and invited me to join this operation, I was immediately on board. I am putting 100 percent of my energy into ensuring the success of the Southern Colorado Operation. I grow the most potent, highest quality strains, and I'm constantly pushing the envelope, and I look forward to putting that knowledge and experience to work for mCig in Colorado. I have access to the absolute best, award-winning cuts and world-renowned strains in the world which we will use to create the finest concentrates available on the planet." The Southern Colorado facility will allow the Extraction Division to field test the upcoming Supercritical Co2 Extractor. 

Rate this blog entry:

Select Your Language


Crowd Funding Campaigns

Featured Listing